TrialBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2020

Ixazomib for Chronic Graft-versus-Host Disease Prophylaxis following Allogeneic Hematopoietic Cell Transplantation.

Saurabh Chhabra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.